Results 201 to 210 of about 72,592 (256)

Multidrug-resistant <i>Pseudomonas aeruginosa</i> infections: current status, challenges, and prospects of phage therapy. [PDF]

Front Microbiol
Yan B, Yan C, Ding Y, Cai S, Wang Y, Agbo E, Xu X, Qin K, Fu Q.   +8 more
europepmc   +1 more source

Efficacy and Efficiency of an Atmospheric Pressure Dielectric Barrier Discharge Reactor (GAPS) for Air Disinfection

Plasma Processes and Polymers, Volume 23, Issue 8, August 2026.
A Grid‐like Air Plasma Sanitiser has been tested for the inactivation of airborne pathogens. This reactor demonstrates a 4.5 and 2.5‐log reduction in aerosolized E. coli and SARS‐CoV‐2, respectively. This device shows an energy efficiency per order index, 2 orders of magnitude lower than values reported for comparable plasma‐based systems.
Silvia G. Scaltriti, Alessia Cantiani, Shannon C. David, Fabio Avino, Tiziana Lazzarotto, Gabriele Neretti, Ivo Furno   +6 more
wiley   +1 more source

Analysis of Pro- and Anti-Inflammatory Gene Response Patterns in Patients Receiving Phage Therapy. [PDF]

Int J Mol Sci
Kasprzak H, Przybylski M, Fortuna W, Letkiewicz S, Rogóż P, Bubak B, Górski A, Międzybrodzki R.   +7 more
europepmc   +1 more source

Pocket restraints guided by B‐cell epitope prediction improve Chai‐1 antibody–antigen structure modeling

Protein Science, Volume 35, Issue 8, August 2026.
Abstract The accurate prediction of antibody–antigen (AbAg) complexes is a key challenge for computational immunology, with applications in therapeutic antibody design and diagnostics. Current deep learning methods have the potential to generate high‐confidence AbAg structures.
Joakim Nøddeskov Clifford, Morten Nielsen   +1 more
wiley   +1 more source

Phage Therapy: Combating Evolution of Bacterial Resistance to Phages. [PDF]

Viruses
Abedon ST.
europepmc   +1 more source

Pseudolysogeny-mediated evolutionary trade-offs favor phage therapy by limiting antibiotic resistance and virulence in Cutibacterium acnes. [PDF]

Sci Rep
Trejo-Hernández A, Checa A, Quijada-Ibarra R, Sepúlveda-Gutíerrez P, Soto S, Andrade-Domínguez A.   +5 more
europepmc   +1 more source

Optimizing phage therapy with artificial intelligence: a perspective. [PDF]

Front Cell Infect Microbiol
Doud MB, Robertson JM, Strathdee SA.
europepmc   +1 more source

Broth Optical Density-Based Assessment for Phage Therapy: Turbidity Reduction, Antibacterial Virulence, and Time-Kill. [PDF]

Viruses
Abedon ST.
europepmc   +1 more source

Microbial keratitis in the age of resistance: unlocking the therapeutic potential of phage therapy. [PDF]

Graefes Arch Clin Exp Ophthalmol
Ibrahim R, Kumar P, Aranjani JM.
europepmc   +1 more source